• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙调神经磷酸酶2调节因子的敲低促进转录因子EB介导的脂质自噬以预防非酒精性脂肪性肝病。

Knockdown of regulator of Calcineurin 2 promotes transcription factor EB-mediated lipophagy to prevent non-alcoholic fatty liver disease.

作者信息

Shan Lei, Guo Pengzhan, Wen Mumeike, Sun Yue, Gao Fei, Zhang Kai, Zhang Ning, Yang Baoshan

机构信息

Department of Infectious Diseases, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, People's Republic of China.

Department of Infectious Diseases, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, People's Republic of China.

出版信息

Toxicol Appl Pharmacol. 2025 Feb;495:117210. doi: 10.1016/j.taap.2024.117210. Epub 2024 Dec 20.

DOI:10.1016/j.taap.2024.117210
PMID:39710154
Abstract

Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease. The present work aimed to explore the function of regulator of Calcineurin 2 (RCAN2) in NAFLD and its related mechanisms. Mice were fed with high-fat diet (HFD) to construct NAFLD model. Adeno-associated virus injection was performed to interference with RCAN2 in mice. RCAN2 knockdown meliorated HFD-induced NAFLD and impaired glucose metabolism. Abnormal lipid metabolism and inflammation in HFD-fed mice were relieved when RCAN2 was downregulated. Besides, hepatocyte Huh-7 cells, treated with free fatty acids (oleic acid and palmitic acid), were used as NAFLD models in vitro. We found that knockdown of RCAN2 inhibited the accumulation of lipid droplets and inflammation induced by free fatty acids. RCAN2 interference increased the activity of calcineurin (CaN), which enhanced the nuclear translocation of Transcription factor EB (TFEB). Autophagosome and lysosome biogenesis was augmented, and autophagy-dependent lipid degradation (lipophagy) was promoted. Collectively, we demonstrate that RCAN2 insufficiency protects against NAFLD by promoting TFEB-mediated lipophagy.

摘要

非酒精性脂肪性肝病(NAFLD)是慢性肝病的主要病因。本研究旨在探讨钙调神经磷酸酶调节蛋白2(RCAN2)在NAFLD中的作用及其相关机制。通过给小鼠喂食高脂饮食(HFD)构建NAFLD模型。采用腺相关病毒注射法干扰小鼠体内的RCAN2。敲低RCAN2可改善HFD诱导的NAFLD并损害葡萄糖代谢。当RCAN2下调时,HFD喂养小鼠的脂质代谢异常和炎症反应得到缓解。此外,用游离脂肪酸(油酸和棕榈酸)处理的肝细胞Huh-7细胞被用作体外NAFLD模型。我们发现敲低RCAN2可抑制游离脂肪酸诱导的脂滴积累和炎症反应。干扰RCAN2可增加钙调神经磷酸酶(CaN)的活性,从而增强转录因子EB(TFEB)的核转位。自噬体和溶酶体生物合成增加,自噬依赖性脂质降解(脂质自噬)被促进。总的来说,我们证明RCAN2功能不足通过促进TFEB介导的脂质自噬来预防NAFLD。

相似文献

1
Knockdown of regulator of Calcineurin 2 promotes transcription factor EB-mediated lipophagy to prevent non-alcoholic fatty liver disease.钙调神经磷酸酶2调节因子的敲低促进转录因子EB介导的脂质自噬以预防非酒精性脂肪性肝病。
Toxicol Appl Pharmacol. 2025 Feb;495:117210. doi: 10.1016/j.taap.2024.117210. Epub 2024 Dec 20.
2
Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy. Phillygenin 通过 TFEB 介导的溶酶体生物发生和脂噬改善非酒精性脂肪性肝病。
Phytomedicine. 2022 Aug;103:154235. doi: 10.1016/j.phymed.2022.154235. Epub 2022 Jun 3.
3
Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease.金丝桃苷通过增强 TFEB 介导线粒体生物发生和脂噬来缓解非酒精性脂肪肝疾病。
Pharmacol Res. 2021 Dec;174:105964. doi: 10.1016/j.phrs.2021.105964. Epub 2021 Oct 31.
4
Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.芒柄花素通过促进 TFEB 介导的溶酶体生物发生和脂噬来减轻肝脂肪变性。
J Nutr Biochem. 2019 Nov;73:108214. doi: 10.1016/j.jnutbio.2019.07.005. Epub 2019 Jul 25.
5
Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.原花青素 B2 通过调节 TFEB 介导线粒体途径和氧化还原状态改善游离脂肪酸诱导的肝脂肪变性。
Free Radic Biol Med. 2018 Oct;126:269-286. doi: 10.1016/j.freeradbiomed.2018.08.024. Epub 2018 Aug 22.
6
The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease.TLR4 通路上调膜联蛋白 A2 通过阻断 AMPK/mTOR 介导的自噬流促进非酒精性脂肪性肝病发展过程中的脂质积累和肝损伤。
Hepatol Int. 2024 Aug;18(4):1144-1157. doi: 10.1007/s12072-023-10622-w. Epub 2024 Jan 6.
7
Trehalose Ameliorates Nonalcoholic Fatty Liver Disease by Regulating IRE1α-TFEB Signaling Pathway.海藻糖通过调节IRE1α-TFEB信号通路改善非酒精性脂肪性肝病。
J Agric Food Chem. 2025 Jan 8;73(1):521-540. doi: 10.1021/acs.jafc.4c08669. Epub 2024 Dec 16.
8
Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy.非诺贝特是一种过氧化物酶体增殖物激活受体α激动剂,可通过上调 TFEB 介导的脂噬作用减少肝脏脂肪堆积。
Metabolism. 2021 Jul;120:154798. doi: 10.1016/j.metabol.2021.154798. Epub 2021 May 11.
9
Tetrahydrocurcumin ameliorates hepatic steatosis by restoring hepatocytes lipophagy through mTORC1-TFEB pathway in nonalcoholic steatohepatitis.四氢姜黄素通过 mTORC1-TFEB 通路恢复肝细胞脂噬改善非酒精性脂肪性肝炎的肝脂肪变性。
Biomed Pharmacother. 2024 Sep;178:117297. doi: 10.1016/j.biopha.2024.117297. Epub 2024 Aug 12.
10
The TFEB activator clomiphene citrate ameliorates lipid metabolic syndrome pathology by activating lipophagy and lipolysis.转录因子EB激活剂枸橼酸氯米芬通过激活脂噬和脂解改善脂质代谢综合征病理状态。
Biochem Pharmacol. 2025 Feb;232:116694. doi: 10.1016/j.bcp.2024.116694. Epub 2024 Dec 4.